Life Sciences Insurance

Pharmaceutical companies operate at the intersection of science, regulation and human impact — and that creates a risk profile unlike any other industry.

You're navigating heightened regulatory scrutiny, product liability exposure across global markets and the operational complexity of supply chains that span continents. Your workforce is often personally connected to the work, creating unique benefits considerations when employees or their families are affected by the conditions your drugs treat.

HUB's pharmaceutical insurance specialists take a whole-enterprise view of your risk, delivering tailored solutions that go well beyond policy placement. Specific consulting and program areas include:

• Supply chain risk assessment
• Contractual risk transfer
• International program coordination
• Industry-specific benchmarking
• Mergers and acquisitions due diligence
• Management systems
• Safety, environmental and regulatory compliance

The medical device landscape is evolving faster than ever. Connected wearables, AI-powered diagnostics, and remote patient monitoring tools are redefining what devices can do — and expanding the risk surface that comes with them.

Data privacy is no longer just an IT concern. When your device collects, transmits, or interprets patient information, every link in that chain carries liability. And when your technology intersects with clinical decision-making, the stakes are even higher.

HUB's medical device specialists understand the full scope of your exposure — from product liability and cybersecurity risk to regulatory compliance and workforce strategy — and will work with you to develop a tailored plan that protects your products, your people and your ability to innovate.

The dietary supplement, nutraceutical and natural health product sector sits at a unique intersection of consumer demand and regulatory complexity — and traditional commercial insurance programs rarely address it with the specificity your operations require.

Regulatory scrutiny is intensifying on both sides of the border. Health Canada's NHP licensing and GMP requirements, combined with the FDA's evolving enforcement posture on claims and new dietary ingredients, create layered cross-border exposure. A product recall, labeling dispute, or adverse event report can move quickly from a compliance issue to a reputational crisis.

HUB's specialists will design a tailored program that reflects your specific product lines, distribution channels, and market obligations — covering product liability and recall expense, contract manufacturer risk transfer, cross-border program coordination and supply chain risk.

CROs, CDMOs, CMOs analytical testing laboratories, and other life sciences service providers occupy a critical position in the drug and device development ecosystem. You don't own the molecules or the products — but when something goes wrong in a study, a batch, or a test result, the liability exposure can fall squarely on you.

The professional liability risks facing service organizations are distinct from those of product companies. Errors in study design, data integrity issues, GMP or GLP deviations and timeline delays all carry meaningful financial and reputational consequences — and standard E&O forms are rarely drafted with your operations in mind.

HUB's specialists bring deep familiarity with the contractual structures, indemnification obligations, and professional exposures that define your business. We'll assess your client contract terms, identify coverage gaps and build a comprehensive risk management solution that holds up when it matters. Specific consulting and program areas include:

• Professional liability / E&O tailored to CRO, CDMO, CMO and lab operations
• Contractual risk transfer and indemnification review
• Clinical trial and study-specific coverage structures
• Intellectual property and data integrity risk
• Pollution and environmental liability (for manufacturing and testing operations)
• Supply chain and third-party vendor risk
• Employee benefits strategy for science and operations talent

R&D is where the most valuable — and most vulnerable — work happens. From the moment an idea takes shape, you're exposed. Intellectual property risks, cybersecurity threats, clinical trial liability and supply chain uncertainty don't wait for your product to reach market.

In today's funding environment, where capital is increasingly concentrated at later stages, protecting early-stage momentum matters more than ever. The right coverage strategy — and the right employee benefits package to attract and retain scientific talent — can make the difference between a pipeline that advances and one that stalls.

HUB's R&D insurance specialists will work with you to identify and manage risk across the full development lifecycle — from prototyping and field testing through regulatory submission and commercialization.

Life sciences insurance is a group of coverages designed to help protect organizations involved in developing, manufacturing or distributing scientific products and technologies. It supports strong life science risk management by addressing exposures tied to research, clinical trials and product development. This type of coverage helps reduce financial losses from liability claims, operational disruptions or equipment issues. It also supports innovation by giving organizations confidence to bring new treatments and technologies to market.

Organizations that develop or manufacture pharmaceuticals, biotechnology products or medical devices need life sciences insurance or life science and biotech insurance. Companies that support the sector, such as contract manufacturers, testing laboratories and research organizations, also benefit from insurance for life sciences companies. Startups working on early research or clinical trials face significant exposures and need insurance for clinical trials to stay protected. Digital health platforms, diagnostic services and device developers also rely on biotech insurance, medical device insurance and other specialized coverage.

Life sciences insurance helps protect organizations from risks tied to product performance, professional services, clinical trials and research activities. Coverage can include protection from product liability, bodily injury, property damage or equipment failure, which is central to life sciences liability insurance. It can also help reduce losses from supply chain interruptions, contamination or research delays. Many organizations also use these policies to address regulatory exposures, cyber threats and data security concerns.

Insurance for life sciences companies is designed to address scientific, regulatory and clinical exposures that standard business insurance does not typically cover. Policies include specialized protections for clinical trials, product liability, biotechnology operations and lab environments, which are not common in general commercial plans. This is why organizations often rely on life science and biotech insurance, biotech insurance and medical device insurance rather than general coverage alone. Standard insurance focuses on basic operational risks, while life sciences programs focus on the unique liabilities that define the industry.

A biotech or medical device company should consider biotech insurance and medical device insurance to help protect against product liability and patient safety risks. Many organizations also need insurance for clinical trials to help manage exposures involving human participants. Property and equipment coverage is important for laboratories, specialized tools and research materials. Cyber insurance and professional liability coverage support ongoing life science risk management across digital systems and scientific services.

Yes, life sciences insurance can include specialized insurance for clinical trials and coverage for a wide range of research activities. Clinical trial protection helps address liability risks involving study participants. Research coverage can help reduce losses from property damage, equipment failure or interruptions in scientific work. These protections support strong life sciences company insurance for organizations conducting research and development.

Product liability within this industry helps protect organizations from claims that a drug, device or biotechnology product caused harm or did not perform as expected. Life sciences liability insurance can help cover legal defense costs, settlements and judgments. Claims can involve design, manufacturing, labeling or performance issues. This type of coverage supports the long-term stability of organizations offering complex scientific products.

Yes, cyber liability is crucial for organizations using life sciences insurance because they handle sensitive research data and intellectual property. A cyber incident can disrupt laboratory work, clinical collaborations or digital health operations. Cyber insurance helps reduce losses tied to breaches, ransomware or system outages and supports broad life sciences company insurance planning. It also helps maintain business continuity and protects reputational trust.

The cost of a life sciences insurance program depends on the type of products or services the organization provides, along with the level of risk in its operations. Clinical trial activity, product complexity, regulatory exposure and claims history can influence premiums in life science and biotech insurance programs. Insurance companies also consider size, revenue, equipment value and where the organization operates. Strong life science risk management practices can help reduce costs by showing insurance companies that risks are being managed thoughtfully.

Yes, organizations can secure global life sciences company insurance to support international operations, product distribution and research activities. These programs help meet local regulatory requirements while maintaining consistent life science and biotech insurance across countries. Coverage can include international liability, property, transportation and supply chain risks. Global insurance programs help life science organizations manage risks in diverse markets with varying standards and rules.